Does RIFAMPIN Cause Hyperleukocytosis? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Hyperleukocytosis have been filed in association with RIFAMPIN (Rifampin). This represents 0.1% of all adverse event reports for RIFAMPIN.
15
Reports of Hyperleukocytosis with RIFAMPIN
0.1%
of all RIFAMPIN reports
0
Deaths
14
Hospitalizations
How Dangerous Is Hyperleukocytosis From RIFAMPIN?
Of the 15 reports, 14 (93.3%) required hospitalization.
Is Hyperleukocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIFAMPIN. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does RIFAMPIN Cause?
Drug ineffective (1,238)
Drug reaction with eosinophilia and systemic symptoms (1,049)
Drug interaction (735)
Pyrexia (735)
Acute kidney injury (684)
Drug-induced liver injury (684)
Off label use (640)
Condition aggravated (597)
Nausea (572)
Paradoxical drug reaction (570)
What Other Drugs Cause Hyperleukocytosis?
CYCLOPHOSPHAMIDE (55)
PREDNISONE (54)
TRETINOIN (52)
ARSENIC TRIOXIDE (49)
RITUXIMAB (49)
ACETAMINOPHEN (44)
VINCRISTINE (44)
DEXAMETHASONE (42)
PANTOPRAZOLE (38)
AMOXICILLIN (36)
Which RIFAMPIN Alternatives Have Lower Hyperleukocytosis Risk?
RIFAMPIN vs RIFAMYCIN
RIFAMPIN vs RIFAPENTINE
RIFAMPIN vs RIFAXIMIN
RIFAMPIN vs RILMENIDINE
RIFAMPIN vs RILONACEPT